| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5671501 | Clinical Microbiology and Infection | 2017 | 32 Pages |
Abstract
Clinical success was more common in FN patients randomized to meropenem compared with the patients randomized to benzylpenicillin plus an aminoglycoside. The all-cause fatality was higher among the patients given benzylpenicillin plus an aminoglycoside.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
D. Torfoss, T. Fladhagen, H. Holte, L. Brinch, F.H. Schjesvold, Y. Fløisand, E. Nyquist, J. Dalgaard, P. Meyer, A.K. Lehmann, J. Hammerstrøm, T. Skjelbakken, E.A. Høiby, L. Sandvik, S. Kvaløy,